Pharming Group NV
AEX:PHARM
Pharming Group NV
AEX:PHARM
Price:
0.891 EUR
1.65%
Market Closed
Updated:
May 2, 2024
Section:
Wall Street
Price Targets
PHARM Price Targets Summary
Pharming Group NV
Pharming Group NV
Wall Street analysts forecast PHARM stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
PHARM
is 1.856 EUR
with a low forecast of 1.515 EUR and a high forecast of 2.205 EUR.
Lowest
Price Target
1.515
EUR
70% Upside
Average
Price Target
1.856
EUR
108% Upside
Highest
Price Target
2.205
EUR
147% Upside
Pharming Group NV Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PHARM's stock price target?
Price Target
1.856
EUR
1.856
EUR
According to Wall Street analysts, the average 1-year price target for
PHARM
is 1.856 EUR
with a low forecast of 1.515 EUR and a high forecast of 2.205 EUR.
What is Pharming Group NV's Revenue forecast?
Projected CAGR
16%
16%
For the last 8 years the
compound annual growth rate for
Pharming Group NV's revenue is
48%.
The projected
CAGR
for the next 3 years is
16%.
You don't have any saved screeners yet
